| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |